Search Results - "Hjortland, G.O"

Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas by Galleberg, R.B, Knigge, U, Tiensuu Janson, E, Vestermark, L.W, Haugvik, S.-P, Ladekarl, M, Langer, S.W, Grønbæk, H, Österlund, P, Hjortland, G.O, Assmus, J, Tang, L, Perren, A, Sorbye, H

“…Abstract Background Gastroenteropancreatic neuroendocrine carcinomas (GEP-NEC) are generally characterized by synchronous metastases, high aggressiveness and a…”
Get full text

1108P Folfirinox in the treatment of advanced gastroenteropancreatic neuroendocrine carsinomas by Butt, B.P., Stokmo, H.L., Ladekarl, M., Mitkina Tabaksblat, E., Sorbye, H., Revheim, M.E., Hjortland, G.O.

Get full text

1235P Enrichment of rare cancers in pragmatic precision cancer medicine trial: Experience from IMPRESS-Norway by Helland, A., Hjortland, G.O., Fagereng, L., Bjorge, L., Gilje, B., Cameron, M.G., Donnem, T., Flobak, A., Fluge, S., Nguyen, O.T.D., Mannsåker, B., Stensvold, A., Russnes, H.E.G., Bjørgo, E., Guren, T.K.K., Smeland, S., Tasken, K.

Get full text

1100MO Molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms by Sorbye, H., Venizelos, A., Elvebakken, H., Perren, A., Lothe, I.M.B., Hjortland, G.O., Sundlov, A., Svensson, J., Garresori, H., Kersten, C., Krogh, M., Detlefsen, S., Knappskog, S.

Get full text

890MO Mutation spectrum in liquid versus solid biopsies from advanced digestive neuroendocrine carcinoma patients by Sorbye, H., Knappskog, S., Grob, T., Venizelos, A., Amstutz, U., Hjortland, G.O., Lothe, I.M., Kersten, C., Hofsli, E., Sundlov, A., Elvebakken, H., Garresori, H., Couvelard, A., Svensson, J., Perren, A.

Get full text

Oncological outcomes of standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer in the multicentre, randomised, controlled NeoRes II trial by Nilsson, K., Klevebro, F., Sunde, B., Rouvelas, I., Lindblad, M., Szabo, E., Halldestam, I., Smedh, U., Wallner, B., Johansson, J., Johnsen, G., Aahlin, E.K., Johannessen, H.-O., Alexandersson von Döbeln, G., Hjortland, G.O., Wang, N., Shang, Y., Borg, D., Quaas, A., Bartella, I., Bruns, C., Schröder, W., Nilsson, M.

“…The optimal time to surgery (TTS) after neoadjuvant chemoradiotherapy (nCRT) for oesophageal cancer is unknown and has traditionally been 4-6 weeks in clinical…”
Get full text

International comparison of treatment strategy and survival in metastatic gastric cancer: a survey from the EURECCA Upper GI group by Claassen, Y., Bastiaannet, E., Hartgrink, H., Dikken, J., De Steur, W., Slingerland, M., Verhoeven, R., Van Eycken, E., De Schutter, H., Lindblad, M., Hedberg, J., Johnson, E., Hjortland, G.O., Jensen, L., Larsson, H., Koessler, T., Chevallay, M., Allum, W., Van de Velde, C.

Get full text

North European comparison of treatment strategy and survival in older patients with resectable gastric cancer: A EURECCA upper gastrointestinal group analysis by Claassen, Y.H.M., Dikken, J.L., Hartgrink, H.H., de Steur, W.O., Slingerland, M., Verhoeven, R.H.A., van Eycken, E., de Schutter, H., Johansson, J., Rouvelas, I., Johnson, E., Hjortland, G.O., Jensen, L.S., Larsson, H.J., Allum, W.H., Portielje, J.E.A., Bastiaannet, E., van de Velde, C.J.H.

“…As older gastric cancer patients are often excluded from randomized clinical trials, the most appropriate treatment strategy for these patients remains…”
Get full text

Intracellular localisation of hypericin in human glioblastoma and carcinoma cell lines by Uzdensky, A B, Ma, L W, Iani, V, Hjortland, G O, Steen, H B, Moan, J

“…Hypericin, a natural polycyclic quinone extracted from Hypericum perforatum, has been recently shown to be a powerful sensitiser for photodynamic therapy…”
Get full text